No Data
No Data
Express News | Equillium Inc - Delivery of Interim Data Review to Ono Pharmaceutical Co. Ltd. (Ono) Expected During Q3 Will Trigger Ono's Option Exercise Period
Earnings Call Summary | ONO PHARMACEUTICAL CO(OPHLF.US) Q1 2024 Earnings Conference
The following is a summary of the Ono Pharmaceutical Co., Ltd. (OPHLF) Q1 2024 Earnings Call Transcript:Financial Performance:Ono Pharmaceutical reported Q1 revenue of ¥502.7 billion, marking their fi
Shareholder Alert: Ademi LLP Investigates Whether Deciphera Pharmaceuticals, Inc. Has Obtained a Fair Price in Its Transaction With ONO Pharmaceutical Co.
MILWAUKEE, April 29, 2024 /PRNewswire/ -- Ademi LLP is investigating Deciphera (NASDAQ: DCPH) for possible breaches of fiduciary duty and other violations of law in its transaction with ONO. Click he
Express News | Deciphera Pharmaceuticals Inc - IF Deal Terminated Under Certain Conditions, Co to Pay Ono Pharmaceutical Co., Ltd a Termination Fee of $78.8 Mln
Ono Pharmaceutical GAAP EPS of ¥229.06, Revenue of ¥389.91B
Ono Pharmaceutical Co. (OPHLF) Upgraded to Buy: Here's Why
No Data